Skip to main content

Peer Review reports

From: Anti-PD-1 antibody in combination with radiotherapy as first-line therapy for unresectable intrahepatic cholangiocarcinoma

Original Submission
1 Oct 2023 Submitted Original manuscript
18 Oct 2023 Reviewed Reviewer Report
3 Nov 2023 Reviewed Reviewer Report
13 Nov 2023 Reviewed Reviewer Report
17 Nov 2023 Reviewed Reviewer Report
16 Dec 2023 Author responded Author comments - Meiyan Zhu
Resubmission - Version 2
16 Dec 2023 Submitted Manuscript version 2
29 Dec 2023 Reviewed Reviewer Report
27 Mar 2024 Author responded Author comments - Meiyan Zhu
Resubmission - Version 3
27 Mar 2024 Submitted Manuscript version 3
Publishing
5 Apr 2024 Editorially accepted
19 Apr 2024 Article published 10.1186/s12916-024-03381-4

You can find further information about peer review here.

Back to article page